Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina

Circulation

Volumn 94, Issue 4, 1996, Pages 610-613

  Fujita, Masatoshi ^a   Ikemoto, Masaki ^a   Kishishita, Masamichi ^a   Otani, Hideo ^a   Nohara, Ryuji ^a   Tanaka, Terumitsu ^b   Tamaki, Shun Ichi ^b   Yamazato, Ario ^b   Sasayama, Shigetake ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Takeda Hospital   (Japan)

Author keywords

collateral circulation; growth substances; ischemia

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

AGED; ANGIOCARDIOGRAPHY; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; NEOVASCULARIZATION (PATHOLOGY); PERICARDIAL EFFUSION; PRIORITY JOURNAL; UNSTABLE ANGINA PECTORIS;

EID: 0029738517     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.4.610     Document Type: Article

References (24)

1. Sasayama S, Fujita M. Recent insights into coronary collateral circulation. Circulation. 1992;85:1197-1204.
2. Schaper W, Sharma HS, Quinkler W, Markert T, Wünsch M, Schaper J. Molecular biologic concepts of coronary anastomoses. J Am Coll Cardiol 1990;15:513-518.
3. Kumar S, Shahabuddin S, Haboubi N, West D, Arnold F, Reid H, Carr T. Angiogenesis factor from human myocardial infarcts. Lancet. 1983;2:364-368.
4. D'Amore PA, Thompson RW. Mechanisms of angiogenesis. Annu Rev Physiol. 1987;49:453-464.
5. Casscells W, Speir E, Sasse J, Klagsbrun M, Allen P, Lee M, Calvo B, Chiba M, Haggroth L, Folkman J, Epstein SE. Isolation, characterization, and location of heparin-binding growth factors in the heart. J Clin Invest. 1990;85:433-441.
6. Braunwald E. Unstable angina: a classification. Circulation. 1989;80:410-414.
7. Rentrop KP, Cohen M, Blanke H, Phillips R. Changes in collateral filling immediately following controlled coronary artery occlusion by an angioplasty balloon in man. J Am Coll Cardiol. 1985;5:587-592.
8. Menzel T, Rahman Z, Calleja E, White K, Wilson EL, Wieder R, Gabrilove J. Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine. Blood. 1996;87:1056-1063.
9. Cohen MV, Vernon J, Yaghdjian V, Hatcher VB. Longitudinal changes in myocardial basic fibroblast growth factor (FGF-2) activity following coronary artery ligation in the dog. J Mol Cell Cardiol. 1994;26:683-690.
10. Klagsbrun M, D'Amore PA. Regulators of Casscellsangiogenesis. Annu Rev Physiol. 1991;53:217-239.
11. Mignatti P, Morimoto T, Rifkin DB. Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner. Proc Natl Acad Sci U S A. 1991;88:11007-11011.
12. Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G. Structural characterization and biological functions of fibroblast growth factor. Endocr Rev. 1987;8:95-114.
13. Yanagisawa-Miwa A, Uchida Y, Nakamura F, Tomaru T, Kido H, Kamijo T, Sugimoto T, Kaji K, Utsuyama M, Kurashima C, Ito H. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science. 1992;257:1401-1403.
14. Unger EF, Banai S, Shou M, Lazarous DF, Jaklitsch HT, Scheinowitz M, Correa R, Klingbeil C, Epstein SE. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol. 1994;266:H1588-H1595.
15. Lazarous DF, Scheinowitz M, Shou M, Hodge E, Rajanayagam S, Hunsberger S, Robison WG Jr, Stiber JA, Correa R, Epstein SE, Unger EF. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation. 1995;91:145-153.
16. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 1992;13:18-32.
17. Ladoux A, Frelin C. Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem Biophys Res Commun. 1993;195:1005-1010.
18. Levy AP, Levy NS, Loscalzo J, Calderone A, Takahashi N, Yeo K, Koren G, Colucci WS, Goldberg MA. Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res. 1995;76:758-766.
19. Senger DR, Perruzzi CA, Feder J, Dvorak HF. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res. 1986;46:5629-5632.
20. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature. 1992;359:845-848.
21. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.
22. Stavri GT, Zachary IC, Baskerville PA, Martin JF, Erusalimsky JD. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells: synergistic interaction with hypoxia. Circulation. 1995;92:11-14.
23. Uchida Y, Yanagisawa-Miwa A, Nakamura F, Yamada K, Tomaru T, Kimura K, Morita T. Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparin sulfate: an experimental study. Am Heart J. 1995;130:1182-1188.
24. Landau C, Jacobs AK, Haudenschild CC. Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia. Am Heart J. 1995;129:924-931.